Obstructive Sleep Apnea in Adults: Common Questions and Answers.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review without systematic search or meta-analysis methodology.
What was done
This narrative clinical review summarized current evidence and recommendations for the screening, diagnosis, and management of obstructive sleep apnea (OSA) in adults, referencing guidance from the U.S. Preventive Services Task Force and clinical practice standards.
What was found
The abstract reports diagnostic criteria and narrative syntheses rather than primary study outcome data. The diagnostic standard is polysomnography showing an apnea-hypopnea index (AHI) greater than 5 with symptoms or greater than 15 without symptoms. The STOP-BANG questionnaire is identified as the most sensitive screening tool. Positive airway pressure is the first-line treatment and weight loss is an effective adjunct. While therapies improve daytime sleepiness and blood pressure, no randomized controlled trials have demonstrated a mortality benefit.
Why it matters
It provides clinicians with a concise synthesis of adult OSA diagnosis and management, highlighting that routine screening in asymptomatic patients is not supported and that mortality reductions remain unproven in randomized trials.
Limits
As a narrative review, it does not use systematic review methodology or report pooled effect sizes, confidence intervals, or study quality assessments. No primary participant data are presented.
Cited by
- context Weight loss is typically a first-line treatment for reducing sleep apnea in individuals with excess body weight.